Skip to main content
BMRN logo

BMRN

BioMarin Pharmaceutical Inc.

$60.43

1.61%

Trade Ideas Performance

Latest Closed Trade Idea

$60.43

1.61%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

14

Social

39

About

Events of BioMarin Pharmaceutical Inc. (BMRN)

Over the past six months, BioMarin's stock was impacted by several events. The Q3 2026 earnings report on November 2, 2026, showed revenues exceeding expectations but lowered full-year revenue and significantly reduced adjusted EPS guidance due to deferred international orders and acquisition-related costs, causing the stock to fall by 2.4%. Acquisitions and licensing agreements in 2026, including Amicus Therapeutics, Alesta Therapeutics, and a license for BMN 450, diversified the portfolio but also impacted EPS guidance. A global settlement with Ascendis Pharma A/S regarding Yuviwel was announced on August 30, 2026. As of November 3, 2026, BMRN stock was trading approximately 23.5% below its 52-week high of $70.98 reached on August 12, 2026.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)